Status:
TERMINATED
Enteral Versus Parenteral Glutamine Supplement
Lead Sponsor:
University Medical Centre Ljubljana
Conditions:
Critically Ill
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
Glutamine is a major fuel for the intestinal tract and immune cells and therefore affects the intestinal permeability (IP) and infection rate at critically ill patients. The preferential route of glut...
Detailed Description
The patients who fulfilled the described criteria were randomly assigned to groups P or E using sequentially numbered containers for concealed randomization. Those in group P received the continuous i...
Eligibility Criteria
Inclusion
- mechanically ventilated critically-ill patients
- older than 18 years
- staying in intensive care unit for at least 4 days
Exclusion
- anuria
- intestinal insufficiency (obstruction, discontinuation of intestine or severe ileus)
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT00875797
Start Date
October 1 2004
End Date
March 1 2009
Last Update
January 16 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General Hospital Slovenj Gradec
Slovenj Gradec, Slovenia